| 12209126 |
Treatment of cancer |
SHAAD ESSA ABDULLAH, Xuyang SONG |
2025-01-28 |
| 10688180 |
Combination of anti-KIR and anti-CTLA-4 antibodies to treat cancer |
Robert Graziano, Su Young Kim, Jon M. Wigginton, Pascale Andre |
2020-06-23 |
| 10604575 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Maria Jure-Kunkel, Xi-Tao Wang, Jon M. Wigginton |
2020-03-31 |
| 10584170 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Maria Jure-Kunkel, Xi-Tao Wang, Jon M. Wigginton |
2020-03-10 |
| 10577423 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Maria Jure-Kunkel, Xi-Tao Wang, Jon M. Wigginton |
2020-03-03 |
| 10494433 |
Combination of anti-KIR and anti-CS1 antibodies to treat multiple myeloma |
Pascale Andre, Mathieu Blery, Cecile Bonnafous, Luisa Salter-Cid, Michael Robbins |
2019-12-03 |
| 10323093 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Maria Jure-Kunkel, Xi-Tao Wang, Jon M. Wigginton |
2019-06-18 |
| 10323092 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Maria Jure-Kunkel, Xi-Tao Wang, Jon M. Wigginton |
2019-06-18 |
| 10316090 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Maria Jure-Kunkel, Xi-Tao Wang, Jon M. Wigginton |
2019-06-11 |
| 10316091 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Maria Jure-Kunkel, Xi-Tao Wang, Jon M. Wigginton |
2019-06-11 |
| 10308714 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Maria Jure-Kunkel, Xi-Tao Wang, Jon M. Wigginton |
2019-06-04 |
| 10266595 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Maria Jure-Kunkel, Xi-Tao Wang, Jon M. Wigginton |
2019-04-23 |
| 10266596 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Maria Jure-Kunkel, Xi-Tao Wang, Jon M. Wigginton |
2019-04-23 |
| 10266594 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Maria Jure-Kunkel, Xi-Tao Wang, Jon M. Wigginton |
2019-04-23 |
| 10138299 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Maria Jure-Kunkel, Xi-Tao Wang, Jon M. Wigginton |
2018-11-27 |
| 10072082 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Maria Jure-Kunkel, Xi-Tao Wang, Jon M. Wigginton |
2018-09-11 |
| 9856320 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Maria Jure-Kunkel, Xi-Tao Wang, Jon M. Wigginton |
2018-01-02 |
| 9789182 |
Combination of anti-KIR and anti-CTLA-4 antibodies to treat cancer |
Robert Graziano, Su Young Kim, Jon M. Wigginton, Pascale Andre |
2017-10-17 |
| 9212224 |
Antibodies that bind PD-L1 and uses thereof |
John P. Cogswell, Stacie M. Goldberg, Maria Jure-Kunkel, Xi-Tao Wang, John M. Wigginton |
2015-12-15 |